Evidence map›Paper›PMID 31419102›Full record

SynthesisThe American journal of managed care2019

Cost of dementia in Medicare managed care: a systematic literature review.

Paul Fishman, Norma B Coe, Lindsay White, Paul K Crane, Sungchul Park, Bailey Ingraham, Eric B Larson

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in The American journal of managed care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Medicare expenditures among spouses of persons with dementia.Journal of the American Geriatrics Society · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cognitive impairment associated with greater care intensity during home health care.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Paul FishmanDepartment of Health Services, University of Washington, 1959 NE Pacific St, Seattle, WA 98185. Email: paulfish@uw.edu.
Norma B Coe
Lindsay White
Paul K Crane
Sungchul Park
Bailey Ingraham
Eric B Larson
Seattle Pacific University · US

Funding

Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicityU01AG006781 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K, LARSON, ERIC B · 1986 to 2020
$39.3M
Current and Future Costs of Alzheimer's and Dementia CareR01AG049815 · NIA · UNIVERSITY OF WASHINGTON · PI COE, NORMA B · 2015 to 2018
$2.1M
EPA EP-C-14-005NIA NIH HHS R01 AG049815NIA NIH HHS U01 AG006781
6 · The paper itself

Abstract

objectivesWe conducted a systematic review of studies reporting the direct healthcare costs of treating older adults with diagnosed Alzheimer disease and related dementias (ADRD) within private Medicare managed care plans. STUDY

designA systematic review of all studies published in English reporting original empirical analyses of direct costs for older adults with ADRD in Medicare managed care.

methodsAll papers indexed in PubMed or Web of Science reporting ADRD costs within Medicare managed care plans from 1983 through 2018 were identified and reviewed.

resultsDespite the growth in Medicare managed care enrollment, only 9 papers report the costs of care for individuals with ADRD within these plans, and only 1 study reports data less than 10 years old. This limited literature reports wide ranges for ADRD-attributable costs, with estimates varying from $3738 to $8726 in annual prevalent costs and $8938 to $38,794 in 1-year immediate postdiagnosis incident costs. Reviewed studies also used varied study populations, case and cost ascertainment methods, and analytic methods, making cross-study comparisons difficult.

conclusionsThe expected continued growth in Medicare managed care enrollment, coupled with the large and growing impact of ADRD on America's healthcare delivery and finance systems, requires more research on the cost of ADRD within managed care. This research should use more consistent approaches to identify ADRD prevalence and provide more detail regarding which components of care are included in analyses and how the costs of care are captured and measured.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseDementiaHealth ExpendituresHumansManaged Care ProgramsMedicareUnited States

Identifiers

PMID31419102
PMCPMC7441813
OpenAlexW2983967471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.